{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-007256","form_type":"8-K","ticker":"VNDA","cik":"0001347178","company_name":"Vanda Pharmaceuticals Inc.","filed_at":"2026-02-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.897140+00:00","generated_at":"2026-05-16T03:14:55.876824+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Vanda FY2025: Fanapt sales +24% to $117.3M; net loss $220.5M; guides 2026 rev $230-260M","bullets":["Fanapt net product sales $117.3M (+24% YoY); total revenues $216.1M (+9%); total prescriptions +28%, NBRx +149%.","Net loss $220.5M ($3.74 diluted EPS) includes $113.7M non-cash valuation allowance; adjusted net loss $106.8M ($1.81 EPS).","FDA approved NEREUS (tradipitant) for motion-induced vomiting; Bysanti NDA PDUFA Feb 21, 2026; imsidolimab BLA submitted.","FY2026 guidance: total revenue $230-260M (Fanapt $150-170M; other products $80-90M).","Cash & equivalents $263.8M as of Dec 31, 2025, down $110.8M from Dec 31, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-007256","json":"https://secwatch.observer/filing/0001628280-26-007256.json","markdown":"https://secwatch.observer/filing/0001628280-26-007256.md","text":"https://secwatch.observer/filing/0001628280-26-007256.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347178/000162828026007256/0001628280-26-007256-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347178/000162828026007256/vnda-20260211.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T03:14:55.876824+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}